Heart Test Laboratories Inc.
HSCS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.62M
Close$
$-2.03
201.1% downside
Current Fair Value
201.1% downsideOvervalued by 201.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.62 Million |
|---|---|
| Enterprise Value | $473.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.34 |
| Beta | 2.04 |
| Outstanding Shares | 3,162,257 |
Return
| Return on Equity | -77727.33% |
|---|---|
| Return on Assets | -27.29% |
| Return on Invested Capital | -24.90% |
Valuation & Multiples
| P/E Ratio | -0.62 |
|---|---|
| PEG | 0.62 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 248.55 |
| Enterprise Value to EBIT | -0.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 8.16 |
| Debt to Equity | 1458.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 16, 2026
EPS Estimate
$-0.84
Average shareholder expectationRevenue Estimate
$200,000
Average shareholder expectationNext Earnings Call
Expected Date
July 22, 2026
EPS Estimate
$-0.84
Average shareholder expectationRevenue Estimate
$50,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data